Anaesthesia and emerging infectious diseases

Anaesthesia and Intensive Care

Volumn 24, Issue 2, 1996, Pages 184-190

  Dwyer, D E ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

Anaesthesia: emerging infectious diseases, local and global pathogens, anaesthesia, workplace practices

Indexed keywords

ANESTHESIA; ANTIBIOTIC RESISTANCE; CONFERENCE PAPER; DISEASE TRANSMISSION; INFECTION; INFECTION CONTROL; INTENSIVE CARE; PRACTICE GUIDELINE; WORKPLACE;

ANESTHESIOLOGY; ANIMALS; ARTHROPOD VECTORS; BLOOD-BORNE PATHOGENS; COMMUNICABLE DISEASES; CROSS INFECTION; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; DRUG RESISTANCE, MICROBIAL; FUNGI; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; INFECTION CONTROL; INTENSIVE CARE;

EID: 0029867557     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (51)

1. Centres for Disease Control. Executive Summary. Addressing emerging infectious disease threats: A prevention strategy for the United States. MMWR 1994; 43:1-18.
2. Ciesielski C, Marianos D, Ou CY, et al. Transmission of human immunodeficiency virus in a dental practice. Ann Int Med 1992; 116:798-805.
3. Chant K, Lowe D, Rubin G, et al. Patient to patient transmission of HIV in private surgical consulting rooms. Lancet 1993; 342:1548-1549.
4. Chant K, Kociuba K, Munro R, et al. Investigation of possible patient to patient transmission of hepatitis C in a hospital. NSW Public Health Bull 1994; 5:47-51.
5. Murray K, Selleck P, Hooper P, et al. A morbillivirus that caused fatal disease in horses and humans. Science 1995; 268:94-97.
6. Krause RM. The dynamics of emergence. J Infect Dis 1994; 170:265-271.
7. Breese Hall C, Long CE, Schnabel KC, et al. Human herpesvirus-6 infection in children. N Engl J Med 1994; 331:432-438.
8. Black JB, Pellet PE. Human herpesvirus 7. Rev Med Virol 1993; 3:217-323.
9. Simons JN, Leary TP, Dawson GJ, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nature Med 1995; 1:564-569.
10. Moaven L, Bowden DS, Locarnini SA. Hepatitis G virus and the hepatitis GB viruses. Todays Life Sciences 1995; 7:24-28.
11. Lok AS, Soldevila-Pico C. The Epidemiology and serologic diagnosis of hepatitis E. J Hepatol 1994; 20:567-569.
12. McGregor AR, Sorrell TC. Infectious Diseases. Med J Aust 1995; 162:104-106.
13. Berkelman RL. Emerging infectious diseases in the United States, 1993. J Infect Dis 1994; 170:272-277.
14. Butler JC, Peters CJ. Hantaviruses and hantavirus pulmonary syndrome. Clin Infect Dis 1994; 19:387-394.
15. Niklasson B, Aaskov J. Serosurvey for antibodies against hantaviruses in humans in northern Australia. Comm Dis Intell 1995; 19:266-267.
16. Menzies D, Fanning A, Yuan L, Fitzgerald M. Tuberculosis among health care workers. N Engl J Med 1995; 332:92-98.
17. Centers for Disease Control, Atlanta, GA. Outbreak of Ebola hemorrhagic fever, Zaire, 1995. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, USA 1995; Abstract LB-12.
18. Matthew FA, Johnson KM. An exotic viral disease acquired in a laboratory. N Engl J Med 1995; 333:317-318.
19. Widmer AF, Hatz C, Formenty P, et al. Ebola virus in Switzerland: Infection control and clinical features of a culture positive case. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, USA 1995; Abstract LB-14.
20. Peters CJ. Arenavirus haemorrhagic fevers: How they wax and wane. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, USA 1995; Abstract S7.
21. Amyus SGB, Thomson CJ. Antibiotic resistance in the ICU. Br J Int Care 1995; 5:263-271.
22. Dwyer DE, Chen SC, Wright E, et al. Hospital practices influence the pattern of infective endocarditis. Med J Aust 1994; 160:709-718.
23. Centers for Disease Control. Nosocomial enterococci resistant to vancomycin. MMWR 1993; 42:597-599.
24. Tomasz A. The pneumococcus at the gates. N Engl J Med 1995; 333:514-515.
25. Neu HC. The crisis in antibiotic resistance. Science 1992; 257:1064-1073.
26. Como JA, Dismukes WE. Oral azole drugs as systemic antifungal therapy. N Engl J Med 1994; 330:263-272.
27. Erice A, Balfour HH. Resistance of human immunodeficiency virus type 1 to antiretroviral agents. Clin Infect Dis 1994; 18: 149-156.
28. Field AK, Biron KK. The end of innocence revisited: Resistance of herpes viruses to antiviral drugs. Clin Microbiol Rev 1004; 7:1-13.
29. Heard RNS. HTLV-1 in Australia. Med J Aust 1993; 159:3-4.
30. Bolton WV Kenrick KG, Dwyer DE, et al. Partial nucleotide sequence analysis of the first case of Human T-lymphotropic virus type 2 from Australia. AIDS Res Hum Retroviruses 1995; 11:765-767.
31. Downie JC, Dwyer DE, Kazazi F, et al. Identification of infection of an Australian resident with the human immunodeficiency virus type 2 (HIV-2). Med J Aust 1992; 157:415-417.
32. Dwyer DE, Ge Y, Naif M, Cunningham AL, Saksena NK. Australian HIV-1 isolates are mostly subtype B, and nucleotide variation differs with acquisition risk factor. Seventh Annual Conference of the Australasian Society for HIV Medicine, Coolum, Australia 1995: Abstract 64.
33. Learmont J, Tindall B, Evans L, et al. Longterm symptomless HIV-1 infection in recipients of blood products from a single donor. Lancet 1992; 340:863-867.
34. Holland DJ, Dwyer DE, Saksena NK, et al. Dementia, pancytopenia and death from AIDS within one year of primary HIV infection. Clin Infect Dis (in press).
35. Cunningham AI, Dwyer DE, Mills J, Montagnier L. The virology of the human immunodeficiency virus. Med J Aust (in press).
36. Menzies R, Tomkins M. Occupationally acquired HIV infection in Australia. Aust HIV Surveillance Report 1995; 11:1-7.
37. Hanna J, Ritchie S, Loewenthal M, et al. Probable Japanese encephalitis acquired in the Torres Strait. Comm Dis Intell 1995; 19:206-207.
38. Lindsay MDA, Johansen CA,Smith DW, et al. An outbreak of Barmah Forest virus disease in the south-west of Western Australia. Med J Aust 1995; 162:291-294.
39. Kay BH, Barker-Hudson P, Stallman ND, et al. Dengue fever: Reappearance in northern Queensland after 26 years. Med J Aust 1984; 1:264-268.
40. Bowden F, Krause V, Burrow J, et al. Hepatitis E in the Northern Territory; a locally acquired case and preliminary evidence suggesting endemic disease. Comm Dis Intell 1994; 18:2-3.
41. NSW Health Department. New South Wales Contingency Plan for cases of possible viral haemorrhagic fevers 1995. State Health Publication No. (PHD) 950114.
42. Riley TV, Pearman JW, Rouse IL. Changing epidemiology of methicillin-resistant Staphylococcus aureus in Western Australia. Med J Aust 1995; 163:412-414.
43. Jones PD. Current perspectives in infectious diseases. RACP Fellowship Affairs 1995; 15-16.
44. Robson JM, Harrison MW, Wood RN, et al. Brucellosis: Reemergence and changing epidemiology in Queensland. Med J Aust 1993; 159:153-158.
45. Bennett SN, McNeil MM, Bland LA, et al. Postoperative infections traced to contamination of an intravenous anesthetic, propofol. N Engl J Med 1995; 333:147-154.
46. Druce JD, Locanini SA, Birch CJ. Isolation of HIV-1 from experimentally contaminated multidose local anaesthetic vials. Med J Aust 1995; 162:513-515.
47. National Health and Medical Research Council of Australia. Creutzfeldt-Jacob disease: Guidelines on patient management and infection control 1995.
48. Gerberding JL. Management of occupational exposures to blood-borne viruses. New Engl J Med 1995; 332:444-451.
49. Adams TI, Harvey BM. Infection Control in Australia. Med J Aust 1995; 163:117-118.
50. McDonald MA, Elford J, Kaldor JM. Reporting of occupational exposures to blood-borne pathogens in Australian teaching hospitals. Med J Aust 1995; 163:121-123.
51. NSW Health Department. HIV and Hepatitis B infected healthcare workers. Circular A11543.